Investigator's Choice of Chemotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Investigator's Choice of Chemotherapy, covering 2026-03-30 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study of YL201 Versus Investigator's Choice of Chemotherapy in Participants With Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-Line Therapy [Phase 3]